Malignant Lymphoma Fellowship Program

The goal of the Malignant Lymphoma Fellowship Program is to train oncologists in the diagnosis and management of all types of lymphoma. Each fellow will have exposure to a variety of research programs and meet clinical and academic goals. At the completion of one year of training, the fellow is expected to be familiar with the natural history of lymphoma, and to be knowledgeable about appropriate diagnostic and therapeutic approaches, including autologous transplant and cellular immunotherapy (CAR T cells). 
 

Contact

Matthew Mei, M.D.
Program Director
City of Hope 
1500 E. Duarte Road 
Duarte, CA 91010
Email: mmei@coh.org
Phone: 800-826-4839

Ofelia Kiedpool, M.S.Ed., C-TAGME
Training Program Coordinator
1500 E. Duarte Road
Duarte, CA 91010
okiedpool@coh.org
626-218-3497

Program Faculty

Current Fellows

  • 2022-2023 - None

Program Graduates

  • 2021-2022 Swetha Kambhampati - City of Hope

Application Process

How To Apply

Up to three positions are available each year. For positions beginning in July, please send a brief cover letter, three letter of references, personal statement, updated CV and the Non-ACGME Standardized application at least a year and a half in advance.

Eligibility

Candidates should be eligible for California licensure. All applicants must be board certified in internal medicine, and board certified or board eligible in hematology/oncology.
 

Contact Information
For further information, contact the program by phone or email: 

Ofelia Kiedpool, M.S.Ed., C-TAGME
Program Administrator
City of Hope 
1500 E. Duarte Road 
Duarte, CA 91010
Email: okiedpool@coh.org
Phone: 626-218-3497

Letter of references should be mailed to the program administrator's attention but addressed to the program director, Matthew Mei, M.D.
 
Please note, we are unable to sponsor visas at this time.

Salary

Salary is commensurate with experience.

Benefits and Policies

Information regarding stipends, benefits and contracts can be found on our Graduate Medical Education homepage.